title: Control of the bioavailability of a topical steroid; comparison of desonide creams 0.05% and 0.1% by vasoconstrictor studies and clinical trials.
authors.forename: B W
authors.initials: BW
authors.lastname: Barry
authors.forename: O
authors.initials: O
authors.lastname: Fyrand
authors.forename: R
authors.initials: R
authors.lastname: Woodford
authors.forename: K
authors.initials: K
authors.lastname: Ulshagen
authors.forename: G
authors.initials: G
authors.lastname: Hogstad
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001682:Biological Availability; D002648:Child; D002986:Clinical Trials as Topic; D003898:Desonide / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004311:Double-Blind Method; D004485:Eczema / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D011246:Pregnadienetriols / Q000493:pharmacokinetics*; D011897:Random Allocation; D012867:Skin / Q000098:blood supply; D014661:Vasoconstriction / Q000187:drug effects
chemical_list: D011246:Pregnadienetriols; D003898:Desonide